MSPs get to benefit from every important IT trend that comes along, whether that's cybersecurity or data and AI,' said FFL's ...

Abacus Group and Medicus IT, two leading providers of IT managed services with deep subject matter expertise in the highly ...

MDCX ’s lead asset is Skinkject, a patented innovative product intended to address the most commonly occurring cancer, which is skin cancer, or Basal Cell Carcinoma (BCC). Skinject is a thumb-sized ...

FFL Partners ("FFL"), a private equity firm focused on growth investments in tech-enabled business services and healthcare companies, today announced the completion of the merger of FFL portfolio ...

Medicus Pharma offers high-risk, high-reward potential, with its novel SkinJect patch for basal cell carcinoma and Antev ...

Review quarterly and annual revenue, net income, and cash flow for Pro Medicus Ltd (PME:XASX) stock through the last fiscal year.

Whenever the healthcare imaging software group signs a new customer contract, fund managers hide under their desks. This latest one really hurts.

Pro Medicus shares have risen 550% over 3 years. Have you missed the boat? Three experts weigh in. The post Is it too late to ...

In April, Medicus Pharma Ltd. MDCX agreed to acquire all of Antev’s issued and outstanding shares on a share exchange. Antev is a clinical-stage biotech company developing Teverelix, ...

ASX 200 healthcare shares led the market last week, propelled by yet another share price surge for market darling Pro Medicus ...

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets.